Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Aurora Cannabis wins rights for licensing talks with CannaRoyalty

Published 2017-12-13, 07:52 a/m
Updated 2017-12-13, 08:00 a/m
© Reuters.  Aurora Cannabis wins rights for licensing talks with CannaRoyalty

Dec 13 (Reuters) - Canadian medical marijuana maker Aurora Cannabis Inc ACB.TO has won the rights to negotiate a licensing deal with CannaRoyalty Corp CRZ.CD that will allow it to sell a range of cannabis-infused consumer products.

Aurora - one of the biggest Canadian cannabis companies - has an exclusive right for 90 days to hammer out a licensing agreement that could give it the rights to sell inhalers, transdermal patches, gels and lotions. which currently only makes medical cannabis, has been seeking deals to offer more products including consumer-oriented products like ones offered by CannaRoyalty, a small Ottawa-based firm.

Alberta-based Aurora is also trying to buy fellow medical marijuana firm CanniMed Therapeutics CMED.TO . deals come amid expectations that Canada will soon legalize the production, sale and consumption of recreational marijuana.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.